Aether Biomedical Sp. z o.o

Aether Biomedical Sp. z o. o, based in Poland, focuses on developing advanced prosthetic solutions, notably the Zeus bionic hand, designed to enhance user independence and functionality in daily activities. Founded in 2018 in Poznan, Poland, Aether Biomedical Sp.

z o. o specializes in innovative prosthetic technology. The company's operations have remained consistent, focused on the development of their flagship product, the Zeus bionic hand. The CEO, Dhruv Agrawal, leads the company as it has successfully raised a total of USD 5.

8 mn through 4 funding deals, the most recent being a Seed round on August 11, 2021, which secured USD 3. 6 mn led by Story Ventures, with participation from Chiratae Ventures, IDG Capital, Joyance Partners, and Sunfish Partners. Aether Biomedical specializes in the development and provision of advanced prosthetic solutions, particularly the Zeus bionic hand. This product offers over 150N of grip force and a lift capacity of 35kgs (77lbs).

Its design includes an impact resistance mechanism that enhances durability and allows for rapid servicing, making it distinct as the only bionic hand that can be repaired by accredited clinicians in under 30 minutes. Aether Biomedical caters to a diverse client base across Europe, North America, and India, significantly improving the quality of life for individuals requiring prosthetic solutions through enhanced functionality and independence. In 2023, Aether Biomedical reported a revenue of USD 1,129,231. 10 with an EBITDA of -USD 713,025.

40, reflecting the company's financial performance in its early growth stages. Aether Biomedical plans to utilize recent funding to expand its product offerings and market reach. The company is exploring new prosthetic designs and aims to enter additional markets in Europe and North America by the end of 2023. The USD 3.

6 mn raised in the Seed funding round will support these initiatives, enhancing their product development and facilitating distribution partnerships.